Acumen Hypotension Prediction Index EV1000 Clinical Platform
Overview
The Acumen Hypotension Prediction Index (HPI) software is a pioneering technology developed by Edwards Lifesciences, designed to detect and help clinicians manage hemodynamic instability and predict the likelihood of hypotensive events. It operates on the HemoSphere Advanced Monitoring Platform, and previously on the EV1000 Clinical Platform. The software utilizes a machine-learning based algorithm that analyzes over 2.6 million features from a single arterial pressure waveform, comparing them against 133 million different waveforms to identify factors that predict hypotension up to 15 minutes before an event.
Key elements of the Acumen HPI software include the HPI Parameter, which displays a value from 0 to 100 indicating the likelihood of a hypotensive event; Smart Alerts and a Smart Trend screen that notify clinicians of potential trends toward hypotension; and a Relationship View screen. This Relationship View provides insights into the root cause of hypotension by visually arranging hemodynamic parameters related to preload, afterload, and contractility.
The Acumen HPI software aims to reduce the incidence and duration of intraoperative hypotension (IOH), which is strongly associated with risks of myocardial injury, acute kidney injury, and mortality. Studies have shown that using Acumen HPI software can significantly reduce the duration of IOH, with one study demonstrating a 57% reduction.
The software can be unlocked by either the minimally-invasive Acumen IQ sensor, which connects to an existing radial arterial line, or the noninvasive Acumen IQ cuff, providing continuous blood pressure and advanced hemodynamic parameters.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- HPI Parameter (0-100 likelihood score)
- Smart Alerts for trending hypotension
- Smart Trend screen
- Relationship View screen (preload, afterload, contractility insights)
- Machine learning-based algorithm for prediction
- Predicts hypotension up to 15 minutes in advance
- Continuous hemodynamic monitoring
- Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options
- Reduces duration of intraoperative hypotension
- Acumen Analytics software for retrospective data analysis
Use Cases
- Prevention of intraoperative hypotension (IOH)
- Management of hemodynamic instability in surgical patients
- Guidance for goal-directed hemodynamic therapy (GDHT)
- Monitoring in non-cardiac surgery
- Monitoring in cardiac surgery
- Patient monitoring in intensive care settings
What Physicians Need to Know
The Acumen HPI software is a decision support tool that provides early warning of impending hypotensive events, allowing for proactive management. It is crucial to use the HPI in conjunction with a comprehensive review of the patient's hemodynamics and not as the sole basis for therapeutic decisions. The secondary screen offering advanced hemodynamic parameters can help identify the underlying cause of hypotension, guiding appropriate interventions. Studies suggest that integrating HPI with a protocolized treatment can lead to a reduction in the incidence and duration of hypotension.
The Acumen HPI software is designed to operate on the Edwards Lifesciences EV1000 Clinical Platform and is compatible with the Acumen IQ sensor (or FloTrac IQ sensor) and an arterial catheter for continuous blood pressure monitoring. It is also integrated with the HemoSphere advanced monitoring platform.
Details
| Category | Cardiology AI, Surgical AI, Triage & ER/ICU AI |
| Pricing | Unknown |
| Deployment | On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) |
| Data Export | Yes |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Cleared AI-estimated The Acumen Hypotension Prediction Index (HPI) software received FDA 510(k) clearance in 2021 for use with the noninvasive Acumen IQ finger cuff. It had previously received De Novo clearance in 2018 for use with invasive arterial lines. The Acumen HPI feature is intended for use in surgical patients receiving advanced hemodynamic monitoring to provide physiological insight into a patient's likelihood of future hypotensive events. |
| SOC 2 | Yes AI-estimated |
| GDPR | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Anesthesiology, Critical Care, Emergency Medicine |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2019-05-21 | K183646 510(k) | Acumen Hypotension Prediction Index EV1000 Clinical Platform |
What the Web Says
The Acumen Hypotension Prediction Index (HPI) on the EV1000 Clinical Platform is an AI-enabled cardiovascular diagnostic tool designed to predict hypotensive events. It is associated with cardiovascular workflows and is utilized by cardiologists and clinical teams in hospital and acute care settings. The system aims to provide real-time insights to help clinicians manage patient hemodynamics.
Overall: PositiveStrengths
- AI-enabled cardiovascular diagnostics product
- Associated with cardiovascular workflows
- Utilized in hospital and inpatient settings
- Used in emergency and acute care
- Supports cardiologists and clinical teams
- Predicts hypotensive events
Limitations
No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.
Based on reviews from: scribd.com, physicianaitools.com, realintelligencereview.com
Last updated: 2026-10-28
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Acumen Hypotension Prediction Index EV1000 Clinical Platform
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Acumen Hypotension Prediction Index EV1000 Clinical Platform.
Frequently Asked Questions
Compare Acumen Hypotension Prediction Index EV1000 Clinical Platform
VS
VS
VS
VS








